StonvexLoading…
StonvexStonvexStonvexCore line items from META's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $56.31B | $200.97B | $141.07B | $89.83B |
Operating Income | $22.87B | $83.28B | $58.53B | $38.00B |
Net Income | $26.77B | $60.46B | $37.69B | $34.98B |
EPS (Diluted) | $10.44 | $23.49 | $14.62 | $13.56 |
Total Assets | $395.25B | $366.02B | $303.84B | $294.74B |
Total Liabilities | $151.57B | $148.78B | $109.78B | $99.67B |
Cash & Equivalents | $23.43B | $35.87B | $10.19B | $12.01B |
Free Cash Flow OCF − CapEx | $13.23B | $46.11B | $31.28B | $20.11B |
Shares Outstanding | 2.56B | 2.57B | 2.58B | 2.58B |